Long-Term Outcome of Patients with Stage II and III Muscle-Invasive Urothelial Bladder Cancer after Multimodality Approach. Which Is the Best Option?

<i>Background and Objectives</i>: There is no consensus regarding the optimal therapy sequence in stage II and III bladder cancer. The study aimed to evaluate the long-term oncologic outcomes in patients with bladder cancer after a multimodality approach. <i>Materials and methods&l...

Full description

Bibliographic Details
Published in:	Medicina
Main Authors:	Oana Gabriela Trifanescu, Laurentia Nicoleta Gales, Mihai Andrei Paun, Natalia Motas, Serban Andrei Marinescu, Ion Virtosu, Raluca Alexandra Trifanescu, Mirela Gherghe, Liviu Bilteanu, Camelia Cristina Diaconu, Rodica Maricela Anghel
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	bladder cancer multimodality treatment chemoradiotherapy neoadjuvant chemotherapy
Online Access:	https://www.mdpi.com/1648-9144/59/1/50

Similar Items

Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma
by: Oana Gabriela Trifanescu, et al.
Published: (2023-01-01)

Prognostic Role of Vascular Endothelial Growth Factor and Correlation with Oxidative Stress Markers in Locally Advanced and Metastatic Ovarian Cancer Patients
by: Oana Gabriela Trifanescu, et al.
Published: (2023-01-01)

The Female Reproductive Tract Microbiome and Cancerogenesis: A Review Story of Bacteria, Hormones, and Disease
by: Oana Gabriela Trifanescu, et al.
Published: (2023-02-01)

Upstaging and Downstaging in Gliomas—Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System
by: Oana Gabriela Trifănescu, et al.
Published: (2023-01-01)

Understanding COVID Vaccination and Its Implication in Cancer Patients’ Imaging of Lymph Nodes by PET-CT
by: Laurentia Nicoleta Gales, et al.
Published: (2022-09-01)

Quantitative vs. Qualitative SPECT-CT Diagnostic Accuracy in Bone Lesion Evaluation—A Review of the Literature
by: Mario-Demian Mutuleanu, et al.
Published: (2023-09-01)

Risk of Myelopathy Following Second Local Treatment after Initial Irradiation of Spine Metastasis
by: Laurentia Gales, et al.
Published: (2023-01-01)

Oncologic Outcome after Pulmonary Metastasectomy as Part of Multidisciplinary Treatment in a Tertiary Oncological Center
by: Natalia Motas, et al.
Published: (2023-01-01)

Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy
by: Laurentia Gales, et al.
Published: (2022-09-01)

Editorial: Cancer risk in patients with acromegaly – is extensive screening needed?
by: Raluca Alexandra Trifănescu, et al.
Published: (2024-10-01)

Management of suspicious nodules in lung cancer screening - a narrative review of monitoring strategies based on nodule features and further needs
by: Rodica Anghel, et al.
Published: (2026-06-01)

Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis—A New Dimension of Molecular Imaging
by: Mirela Gherghe, et al.
Published: (2023-05-01)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
by: Hyun Hwan Sung, et al.
Published: (2022-03-01)

Our Experience and Literature Update Regarding Concomitant Radiotherapy with CDK4/6 Inhibitors and Hormonal Therapy in Metastatic Breast Cancer
by: Laura-Florentina Rebegea, et al.
Published: (2025-05-01)

Outcome of breast cancer patients regarding obesity and complications: Analysis of risk factors
by: Iuliana Pantelimon, et al.
Published: (2021-03-01)

THE ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER
by: Anca Zgura, et al.
Published: (2018-09-01)

Treating malignant melanoma when a rare BRAF V600M mutation is present: case report and literature review
by: Popescu Andrei, et al.
Published: (2018-06-01)

Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment
by: A. E. Kuzminov, et al.
Published: (2020-07-01)

Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours
by: Mirela Gherghe, et al.
Published: (2023-01-01)

Quality of life in patients with pan-cancer undergoing concurrent chemoradiotherapy: a bibliometric analysis (1995-2024)
by: Ao Shen, et al.
Published: (2025-08-01)

Perioperative treatment of gastric cancer- short review
by: Josipa Flam, et al.
Published: (2021-01-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
by: Mao‐Chih Hsieh, et al.
Published: (2018-06-01)

Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
by: Jinbiao Xu, et al.
Published: (2025-05-01)

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
by: Wing-Keen Yap, et al.
Published: (2022-11-01)

Clinicopathological Characteristics and Treatment Patterns of Extremity, Trunk, and Axial Sarcomas: A Descriptive Real-World Cohort Study from a Romanian Tertiary Oncology Center
by: Mihai-Teodor Georgescu, et al.
Published: (2026-05-01)

High mortality risk among women with acromegaly still persists
by: Simona Găloiu, et al.
Published: (2024-02-01)

Improvement of acromegaly control with multimodal therapy in Romania
by: Mihai C. Marinescu, et al.
Published: (2020-06-01)

The management of brain metastases in ALK-positive NSCLC patients
by: Alexandru-Ioan Pintea, et al.
Published: (2024-01-01)

Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
by: Weiwei Li, et al.
Published: (2023-03-01)

A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
by: Tian Zhang, et al.
Published: (2022-08-01)

Magnetic Resonance Imaging Value to Predict Pathologic Staging in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation
by: Carolina De La Pinta, et al.
Published: (2019-03-01)

The influence of surgery quality on the longtime results of gastric cancer combination therapy
by: Ireneusz Pierzankowski, et al.
Published: (2022-08-01)

Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients
by: V. A. Titova, et al.
Published: (2014-08-01)

The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapy
by: Ling Xiao, et al.
Published: (2022-03-01)

Consolidation Chemotherapy Provided Survival Benefit for Esophageal Squamous Cell Carcinoma Patients Who Underwent Concurrent Chemoradiotherapy Lower Than 60 Gy
by: Hualei Zhang, et al.
Published: (2025-04-01)

Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
by: Jifang Zheng, et al.
Published: (2023-12-01)

A STUDY OF ADJUVANT CONCURRENT CHEMO-RADIOTHERAPY WITH CAPECITABINE IN ADENOCARINOMA STOMACH
by: Vishesh Gumdal, et al.
Published: (2016-12-01)

Secondary ALL after Successful Treatment of Ewing's Sarcoma: A Case Report
by: Kourosh Goudarzi Pour, et al.
Published: (2016-10-01)

Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II–III resectable rectal cancer: 5-Year survival data of a randomized controlled trial
by: Laura Kairevičė, et al.
Published: (2017-01-01)